Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vagitocin Dose-Finding Study for Vaginal Atrophy
NCT01987804Phase 2Completed
- Sponsor
- Peptonic Medical
- Start
- Jan 2012
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vagitocin in vaginal atrophy, sponsored by Peptonic Medical. Started Jan 2012; status: completed.
02
Drugs
vagitocin
03
Conditions
vaginal atrophy
Beyond the preview
Go deeper on NCT01987804.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987804.